logo-large
  • Browse Categories

Publications by authors named "Ute Kossak-Roth"

Claim this Profile
D
Diagnostic performance of the molecular BCR-ABL1 monitoring system may impact on inclusion of CML patients in stopping trials.
Birgit Spiess, Sébastien Rinaldetti, Nicole Naumann, Norbert Galuschek, Ute Kossak-Roth

PLoS One· December 2019


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.
Birgit Spiess, Nicole Naumann, Norbert Galuschek, Sébastien Rinaldetti, Ute Kossak-Roth

PLoS One· August 2018


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias].
Ute Kossak-Roth, Susanne Saußele, Carlo Aul, Thomas Büchner, Hartmut Döhner

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz· April 2016


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals? GIMEMA and EORTC Quality of Life Group.
Fabio Efficace, Massimo Breccia, Susanne Saussele, Ute Kossak-Roth, Annarita Cardoni

Ann Hematol· September 2012


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: